Literature DB >> 26000542

Committee opinion no. 634: Hereditary cancer syndromes and risk assessment.

.   

Abstract

A hereditary cancer syndrome is a genetic predisposition to certain types of cancer, often with onset at an early age, caused by inherited mutations in one or more genes. Cases of cancer commonly encountered by obstetrician-gynecologists or other obstetric-gynecologic providers--such as breast cancer, ovarian cancer, and endometrial cancer--are features of specific hereditary cancer syndromes. The most common hereditary cancer syndromes related to gynecologic cancer include hereditary breast and ovarian cancer syndrome, Lynch syndrome, Li-Fraumeni syndrome, Cowden syndrome, and Peutz-Jeghers syndrome. A hereditary cancer risk assessment is the key to identifying patients and families who may be at increased risk of developing certain types of cancer. Screening should include, at minimum, a personal cancer history and a first- and second-degree relative cancer history that includes a description of the type of primary cancer, the age of onset, and the lineage (paternal versus maternal) of the family member. In addition, a patient's ethnic background can influence her genetic risk. If a hereditary cancer risk assessment suggests an increased risk of a hereditary cancer syndrome, referral to a specialist in cancer genetics or a health care provider with expertise in genetics is recommended for expanded gathering of family history information, risk assessment, education, and counseling, which may lead to genetic testing.

Entities:  

Mesh:

Year:  2015        PMID: 26000542     DOI: 10.1097/01.AOG.0000466373.71146.51

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

Review 1.  Cancer Genetic Counseling-Current Practice and Future Challenges.

Authors:  Jaclyn Schienda; Jill Stopfer
Journal:  Cold Spring Harb Perspect Med       Date:  2020-06-01       Impact factor: 5.159

2.  Impact of a genetic counseling requirement prior to genetic testing.

Authors:  David D Stenehjem; Trang Au; Amy M Sainski; Hillevi Bauer; Krystal Brown; Johnathan Lancaster; Vanessa Stevens; Diana I Brixner
Journal:  BMC Health Serv Res       Date:  2018-03-07       Impact factor: 2.655

3.  Clinical utility of a self-administered questionnaire for assessment of hereditary gynecologic cancer.

Authors:  Kenta Masuda; Akira Hirasawa; Haruko Irie-Kunitomi; Tomoko Akahane; Arisa Ueki; Yusuke Kobayashi; Wataru Yamagami; Hiroyuki Nomura; Fumio Kataoka; Eiichiro Tominaga; Kouji Banno; Nobuyuki Susumu; Daisuke Aoki
Journal:  Jpn J Clin Oncol       Date:  2017-05-01       Impact factor: 3.019

4.  Case Report of Menopausal Woman Diagnosed with Endometrial Cancer after Colon Cancer with Germline Mutation in MSH6 in Korea.

Authors:  Hyun Jung Lee; Min Hee Lee; Min Chul Choi; Sang Geun Jung; Won Duk Joo; Tae Hoen Kim; Chan Lee; Ja-Hyun Jang
Journal:  J Menopausal Med       Date:  2017-04-28

5.  Germline mutations in Thai patients with nonmucinous epithelial ovarian cancer.

Authors:  Tarinee Manchana; Prasit Phowthongkum; Chinachote Teerapakpinyo
Journal:  World J Clin Oncol       Date:  2019-11-24

6.  Examining the Diagnostic Yield of Tumour Testing and Qualifying Germline Concordance for Hereditary Cancer Variants in Patients with High-Grade Serous Carcinoma.

Authors:  Emily A Goebel; Jennifer Kerkhof; Oleksandra Dzyubak; C Meg McLachlin; Jacob McGee; Bekim Sadikovic
Journal:  Genes (Basel)       Date:  2022-08-06       Impact factor: 4.141

7.  WRN Germline Mutation Is the Likely Inherited Etiology of Various Cancer Types in One Iranian Family.

Authors:  Mahnaz Norouzi; Mohammad Shafiei; Zeinab Abdollahi; Paniz Miar; Hamid Galehdari; Mohammad Hasan Emami; Mehrdad Zeinalian; Mohammad Amin Tabatabaiefar
Journal:  Front Oncol       Date:  2021-06-07       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.